John Zentgraf, CEO
Mark Meyerhoff, PhD, Technical Advisor
Alexander S. Yevzlin, MD, CMO
Mr. Zentgraf has 40+ years medical device industry experience including 21 years with Guidant where he led a team of 1,300 engineers and scientists through all phases of implantable product development, basic and applied research, and advanced technology development.
Mr. Zentgraf is an experienced entrepreneur, co-founding Phraxis Inc, Ab
Mr. Zentgraf has 40+ years medical device industry experience including 21 years with Guidant where he led a team of 1,300 engineers and scientists through all phases of implantable product development, basic and applied research, and advanced technology development.
Mr. Zentgraf is an experienced entrepreneur, co-founding Phraxis Inc, Abilitech Medical, and Neochord Inc, and leading products through regulatory approval in the United States and Europe.
Mr. Zentgraf has extensive experience in analyzing emerging clinical technology, defining product requirements, executing design-control development, building FDA-compliant quality systems, and contract manufacturing design transfer process.
Alexander S. Yevzlin, MD, CMO
Mark Meyerhoff, PhD, Technical Advisor
Alexander S. Yevzlin, MD, CMO
Dr. Yevzlin is Professor of Medicine and Director of Interventional Nephrology at the University of Michigan. Dr. Yevzlin’s success in bringing innovative solutions to reduce infections among the ESRD community earned him the KidneyX Phase I Prize. Dr. Yevzlin is a seasoned entrepreneur, co-founding Phraxis Inc and R4 Vascular and has ser
Dr. Yevzlin is Professor of Medicine and Director of Interventional Nephrology at the University of Michigan. Dr. Yevzlin’s success in bringing innovative solutions to reduce infections among the ESRD community earned him the KidneyX Phase I Prize. Dr. Yevzlin is a seasoned entrepreneur, co-founding Phraxis Inc and R4 Vascular and has served as Chief
Medical Officer for Cytopherx and AV-Medical. Dr. Yevzlin is an accomplished author and researcher in the field of interventional nephrology and has published or presented hundreds of manuscripts, abstracts, and invited lectures. Dr. Yevzlin earned his medical degree from Ohio State University and BA from Dartmouth College.
.png/:/cr=t:6.8%25,l:20.51%25,w:62.5%25,h:48.03%25/rs=w:365,h:365,cg:true,m/fx-gs)
Mark Meyerhoff, PhD, Technical Advisor
Mark Meyerhoff, PhD, Technical Advisor
Mark Meyerhoff, PhD, Technical Advisor
Dr. Meyerhoff is the Philip J. Elving Professor of Chemistry at the University of Michigan where he has taught for over 40 years. His research laboratory has been active for more than 20 years in the field of nitric oxide (NO) release materials and their characterization, with emphasis on novel NO releasing polymers and their use for anti
Dr. Meyerhoff is the Philip J. Elving Professor of Chemistry at the University of Michigan where he has taught for over 40 years. His research laboratory has been active for more than 20 years in the field of nitric oxide (NO) release materials and their characterization, with emphasis on novel NO releasing polymers and their use for antimicrobial and antithrombotic applications in medicine.
Dr. Meyerhoff continually translates his research to medical industry application, and has earned many awards and honors over his storied research career, the most recent being the ACS Award in Analytical Chemistry (2020), the Adams Award in Bioanalytical Chemistry (2014), and Distinguished Faculty Achievement Award at University of Michigan (2011). Dr. Meyerhoff has authored over 400 publications.
Dr. Meyerhoff earned his BA from Herbert H. Lehman College (CUNY), and his PhD in Analytical Chemistry from SUNY-Buffalo.